Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease

doi:10.3748/wjg.v28.i30.4102

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 30

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5433)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

264

WORD

HTML

2676

Figures (1-3)

513

Tables (1-4)

310

Sum=3811

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

355

Download

1267

Sum=1622

Aug 14, 2022 (publication date) through Oct 3, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Aug 14, 2022; 28(30): 4102-4119
Published online Aug 14, 2022. doi: 10.3748/wjg.v28.i30.4102

Open in New Tab Full Size Figure Download Figure

Figure 1 Flowchart of inflammatory bowel disease selection and analysis. CD: Crohn’s disease; UC: Ulcerative colitis; ASA: Aminosalicylates; CS: Corticosteroids; IMS: Immunosuppressants; IFX: Infliximab.

Open in New Tab Full Size Figure Download Figure

Figure 2 Temporal trends in medication use in patients with inflammatory bowel disease. A: Trends in medication use in patients with Crohn’s disease; B: Trends in medication use in patients with ulcerative colitis. ASA: Aminosalicylates; CS: Corticosteroids; IMS: Immunosuppressants; IFX: Infliximab.

Open in New Tab Full Size Figure Download Figure

Figure 3 Periodic changes in treatment patterns in patients with inflammatory bowel disease. A: Crohn’s disease; B: Ulcerative colitis. ASA: Aminosalicylates; CS: Corticosteroids; IMS: Immunosuppressants; IFX: Infliximab.

Citation: Yao LY, Shao BL, Tian F, Ye M, Li YQ, Wang XL, Wang L, Yang SQ, Lv XP, Jia Y, Wang XH, Zhang XQ, Wei YL, Cao Q. Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease. World J Gastroenterol 2022; 28(30): 4102-4119
URL: https://www.wjgnet.com/1007-9327/full/v28/i30/4102.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i30.4102